Biotech Stock Plunges on Bitcoin Plans as Ethereum Treasuries Stay Hot
Lixte Biotechnology's share price fell hard after it revealed a Bitcoin treasury, while firms stashing Ethereum have been surging of late.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This ethereum story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Binance Becomes a Circle Shareholder in $100 Million Stock Sale Tied to USDC Deal
Circle sold 1,237,011 shares of its Class A common stock to Binance for $100 million and agreed to pay the exchange a recurring fe...
Ondo Unlocks $3.6B Tokenized Market With Direct Stock-to-Token Conversions
Key Takeaways: Ondo Finance has now introduced the ease of converting legacy shares into tokenized stocks and ETFs for approved in...
ETH USD Loses Ground as Ethereum Price Analysis Remains Targeting $3,000 This Week
Ethereum Price Prediction, September 23: Ethereum (ETH) trades at $2,735, down a marginal 0.61% over the past 24 hours, a pause, n...
Solana flips Ethereum in fees, while ETH holds the burn lead
Solana generated more user fees than Ethereum in data provider DefiLlama's Sept. 22 dashboard snapshot, while Ethereum burned more...
Arch Lending eyes tokenized stocks as next collateral market
Arch Lending’s Himanshu Sahay said on Cointelegraph’s Chain Reaction podcast that the lender plans to move into tokenized equities...
Bitcoin may go quantum-safe while Lightning privacy stays exposed
Even if Bitcoin eventually adopts post-quantum protections for on-chain outputs, five parts of the Lightning Network’s off-chain p...